Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Use of Rapid Response EEG Impact Clinical Decision Making

NCT03534258 is registered in ClinicalTrials.gov with Ceribell Inc. as lead sponsor.

NCT NCT03534258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03534258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Use of Rapid Response EEG Impact Clinical Decision Making
Lead sponsor
Ceribell Inc.
Phase
Observational
Overall status
Completed
Start date
April 30, 2018
Completion date
July 31, 2019
Enrollment
164 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

nonconvulsive status epilepticus, seizures